AJMC Staff

Johnson & Johnson began their largest trial yet testing a coronavirus disease 2019 (COVID-19) vaccine; a study finds college openings fueled COVID-19 cases; the FDA is expected to release stricter vaccine authorization guidelines.

Financial worries rise among rural hospitals as federal government loans become due; a report finds shortages of supplies are impeding the COVID-19 response; the effect of COVID-19 on the heart is spotlighted.

The 2-year study will investigate how devices like the Apple Watch and the iPhone can help patients with asthma better manage their condition.

Nivolumab, a checkpoint inhibitor, and cabozantinib, a targeted therapy, produced dramatic results when used in combination for patients with newly diagnosed advanced kidney cancer.

The CDC abruptly pulled guidance saying that COVID-19 is primarily spread via airborne transmission; HHS issues memo stating that the FDA no longer has the authority to sign any new rules on food, vaccines; a novel study examines risk of infection during a flight.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

If approved, FoundationOne's CDx would be used to identify patients with non–small cell lung cancer (NSCLC) who are eligible for mobocertinib or brigatinib.

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

Europe sees an increase in COVID-19 cases; CDC releases data on racial disparities in fetal deaths; an update to COVID-19 testing strategies skipped CDC internal review.

CareFirst BlueCross BlueShield, MedStar Health announce partnership; HHS official takes medical leave; Trump administration releases vaccine rollout plan.

Wearing masks may not stop the spread of coronavirus disease 2019 (COVID-19) via restaurants; COVID-19 trials need more Black participants; the pandemic has disproportionately disrupted HIV care services in the South.

NIH investigates a serious side effect from a COVID-19 vaccine trial; a report says the pandemic has erased 25 years' worth of global health gains; the US seeks to extend a ban on global health aid for foreign organizations that provide or promote abortions.

Poor air quality from wildfires may have an impact on mental health; a new executive order to lower prescription drug prices; Pfizer and BioNTech will expand the phase 3 trial of their COVID-19 vaccine.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

The analysis, which was released on the first day of the meeting, was one of many that tried to demonstrate that earlier treatment in newly diagnosed and younger patients may forestall disease progression and disability.

A trial investigating an experimental treatment for patients with cancer, coronavirus disease 2019 (COVID-19) begins; new research outlines COVID-19 risks for young adults; federal regulators issue OSHA fine.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

The same group of patients had their homocysteine level tested when their COPD was exacerbated and also when it was not.

Most adults are reluctant to receive a coronavirus disease 2019 (COVID-19) vaccine if it is approved before November; airports will stop screening international travelers for COVID-19; surveys show a sharp decline in youth vaping.

A study suggests cardiac rehabilitation offers the most benefits to patients who start out with more advanced renal disease.

AstraZeneca's phase 3 trial of a coronavirus disease 2019 (COVID-19) vaccine has been temporarily stopped; the Sturgis Motorcycle Rally may have led to over 250,000 COVID-19 cases; a potential treatment for breast cancer may not be effective.

Nine pharmaceutical companies issued a joint pledge that seeks to reassure the public about the safety, efficacy of their potential vaccines; fatigue, headache, and fever were indicated as the most common symptoms of COVID-19 in children; the link between vaping use and risk of COVID-19 infection and adverse outcomes becomes clear.

For patients with systemic sclerosis, myopathy is a risk factor for worse outcomes and survival, according to a recent study.

In clinical practice, lasmiditan may be given together with propranolol; investigators wanted to test the cardiovascular effects of coadministration.

A small study says that gloves with sensors could measure impairments in hand function and may have advantages over standard methods.

Combining chimeric antigen receptor (CAR) T-cell therapy and an oncolytic virus were more potent against solid tumors than CAR T-cell therapy alone in mouse models of cancer.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Sanofi and GSK begin human trials for their COVID-19 vaccine; steroids prove effective in severe COVID-19 cases; a drug combination poses a breakthrough in ALS treatment.

Medicare patients can now get the FreeStyle Libre 2 continuous glucose monitor (CGM); Anthony S. Fauci, MD, discussed the chance of an early release of a COVID-19 vaccine; US backs out of World Health Organization’s vaccine initiative.

Coronavirus disease 2019 (COVID-19)–related hospitalizations and deaths of children and teens are on the rise; vaccine experts warn against rushing a COVID-19 vaccine; 2 studies spotlighted the airborne spread of COVID-19.